Annual CAPEX
$505.00 K
+$387.00 K+327.97%
31 December 2023
Summary:
Cidara Therapeutics annual capital expenditures is currently $505.00 thousand, with the most recent change of +$387.00 thousand (+327.97%) on 31 December 2023. During the last 3 years, it has risen by +$319.00 thousand (+171.51%). CDTX annual CAPEX is now at all-time high.CDTX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 September 2024
Summary:
Cidara Therapeutics quarterly capital expenditures is not available.CDTX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 September 2024
Summary:
Cidara Therapeutics TTM capital expenditures is not available.CDTX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CDTX CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +328.0% | - | - |
| 3 y3 years | +171.5% | - | - |
| 5 y5 years | - | - | - |
CDTX CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1131.7% | ||||
| 5 y | 5 years | at high | +1342.9% | ||||
| alltime | all time | at high | +1342.9% |
Cidara Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $0.00(-100.0%) | $327.00 K(-24.7%) |
| Mar 2024 | - | $23.00 K(-87.1%) | $434.00 K(-14.1%) |
| Dec 2023 | $505.00 K(+328.0%) | $178.00 K(+41.3%) | $505.00 K(+50.3%) |
| Sept 2023 | - | $126.00 K(+17.8%) | $336.00 K(+53.4%) |
| June 2023 | - | $107.00 K(+13.8%) | $219.00 K(+71.1%) |
| Mar 2023 | - | $94.00 K(+944.4%) | $128.00 K(+8.5%) |
| Dec 2022 | $118.00 K(+187.8%) | $9000.00(0.0%) | $118.00 K(+8.3%) |
| Sept 2022 | - | $9000.00(-43.8%) | $109.00 K(-2.7%) |
| June 2022 | - | $16.00 K(-81.0%) | $112.00 K(-0.9%) |
| Mar 2022 | - | $84.00 K(>+9900.0%) | $113.00 K(+175.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $41.00 K(-78.0%) | $0.00(-100.0%) | $41.00 K(0.0%) |
| Sept 2021 | - | $12.00 K(-29.4%) | $41.00 K(-50.6%) |
| June 2021 | - | $17.00 K(+41.7%) | $83.00 K(-48.8%) |
| Mar 2021 | - | $12.00 K(>+9900.0%) | $162.00 K(-12.9%) |
| Dec 2020 | $186.00 K(+431.4%) | $0.00(-100.0%) | $186.00 K(0.0%) |
| Sept 2020 | - | $54.00 K(-43.8%) | $186.00 K(+40.9%) |
| June 2020 | - | $96.00 K(+166.7%) | $132.00 K(+266.7%) |
| Mar 2020 | - | $36.00 K(>+9900.0%) | $36.00 K(>+9900.0%) |
| Dec 2019 | $35.00 K | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2019 | - | $0.00 | $0.00 |
FAQ
- What is Cidara Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Cidara Therapeutics?
- What is Cidara Therapeutics annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for Cidara Therapeutics?
- What is the all time high TTM CAPEX for Cidara Therapeutics?
What is Cidara Therapeutics annual capital expenditures?
The current annual CAPEX of CDTX is $505.00 K
What is the all time high annual CAPEX for Cidara Therapeutics?
Cidara Therapeutics all-time high annual capital expenditures is $505.00 K
What is Cidara Therapeutics annual CAPEX year-on-year change?
Over the past year, CDTX annual capital expenditures has changed by +$387.00 K (+327.97%)
What is the all time high quarterly CAPEX for Cidara Therapeutics?
Cidara Therapeutics all-time high quarterly capital expenditures is $178.00 K
What is the all time high TTM CAPEX for Cidara Therapeutics?
Cidara Therapeutics all-time high TTM capital expenditures is $505.00 K